FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/26/2026
Back to search
Official data from USPTO
NEURODYX THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
NEURODYX THERAPEUTICS
ST13
US500000079390854Class
5, 42, 44
Filing
79390854
Registration
7830480
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 42, 44
Filing date
12/18/2023
Registration date
06/17/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
34
Owner location
Paris, FR
Examiner
HUDSON, TAMARA BREE
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
NEURODYX
B. F. (pessoa física)
Representatives
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for the treatment of neuroinflammation and diseases and disorders of the central nervous system; sanitary preparations for medical use; dietetic beverages and foodstuffs for medical or veterinary usefood for babies; dietary supplements for humans and animals; medical and surgical plasterswound dressings; materials for dental fillings and dental impressions; disinfectants; preparations for destroying vermin; fungicidesherbicides; chemical preparations for medical or pharmaceutical use for the treatment of neuroinflammation and diseases and disorders of the central nervous system
Class 42
Medical researchresearch in pharmaceuticalsbiologychemistrybacteriologycosmetology; conducting technical project studies for determining the feasability of new technologies; surveying being engineering work; research and development of new products for others; scientific research and advisory services in the medicalpharmaceuticalcosmeticveterinaryfoodchemical and biology fieldconducting scientific research in the nature of laboratory testsin vivo and in vitro clinical trialsconcerning different materialsproducts or devices in the medicalpharmaceuticalcosmeticveterinaryfoodchemical and biology fields; scientific research featuring chemicalbiologicalpharmaceutical analysis services; design and development of tests for carrying out these analyses; conducting of new product tests and analysesin particular in the pharmaceutical field; scientific research services for carrying out clinical studies for the cosmeticpharmaceuticalfood and veterinary industries; scientific research featuring clinical trials of medicines and medical devices
Class 44
Medical pharmacy advice; medical services; healthcare services; health care and medicalparamedicalhygiene services in the nature of providing hot tub and bath facilities for hygiene purposes and beauty care services
Publications
History of USPTO decisions and trademark events.
39 publications found
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/14/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
01/14/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/17/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/22/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/06/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/06/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/17/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
06/17/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/29/2025
PUBO
PUBLISHED FOR OPPOSITION
04/29/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/23/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/31/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/20/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/20/2025
NREV
NOTICE OF REVIVAL - E-MAILED
03/20/2025
PETG
PETITION TO REVIVE-GRANTED
03/20/2025
PROA
TEAS PETITION TO REVIVE RECEIVED
03/20/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/20/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/20/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/20/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/20/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/20/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/20/2025
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
02/24/2025
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
02/24/2025
RFNT
REFUSAL PROCESSED BY IB
08/25/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/08/2024
RFRR
REFUSAL PROCESSED BY MPU
08/08/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/24/2024
CNRT
NON-FINAL ACTION WRITTEN
07/23/2024
DOCK
ASSIGNED TO EXAMINER
07/16/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/24/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
04/13/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/13/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/10/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/07/2024
Continuous trademark protection
Get notified about every new filing that threatens NEURODYX THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.